SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                  -------------

                                    FORM 10-Q

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended December 31, 1997

                         Commission File number: 0-28202

                            WALSH INTERNATIONAL INC.
             (Exact Name of Registrant as Specified in its Charter)

            Delaware                                         51-0309207
   (State or Other Jurisdiction                         (I.R.S. Employer
 of Incorporation or Organization)                     Identification Number)

    105 Terry Drive, Suite 118, Newtown, Pennsylvania 18940
(Address of Principal Executive Offices)                (Zip Code)

Registrant's Telephone Number, Including Area Code   215-860-4949

           ----------------------------------------------------------
              (Former Name, Former Address and Former Fiscal Year,
                         if Changed Since Last Report)


          Indicate by check mark whether the  registrant (1) has filed
          all  reports  required to be filed by Section 13 to 15(d) of
          the Securities  Exchange Act of 1934 during the preceding 12
          months (or for such shorter  period that the  registrant was
          required to file such reports),  and (2) has been subject to
          such filing requirements for the past 90 days Yes x No

          As of January  23,  1998 there were  outstanding  10,595,099
          shares of Common Stock of Walsh International Inc.


<PAGE>



                    WALSH INTERNATIONAL INC. AND SUBSIDIARIES

                               INDEX TO FORM 10-Q


                                                                     Page Number


PART I   FINANCIAL INFORMATION

Item 1.  Financial statements

         Consolidated  Statements  of Operations  (unaudited)  for the
         Three and Six Months Ended December 31, 1997 and 1996...........3

         Consolidated  Balance  Sheets  (unaudited) as of December 31,
         1997 and June 30, 1997..........................................4

         Consolidated Statements of Cash Flows (unaudited) for the Six
         Months Ended December 31, 1997 and 1996.........................5

         Notes to Consolidated Financial Statements......................6


Item 2.  Management's Discussion and Analysis of Results of Operations
         and Financial Condition........................................10


PART II  OTHER INFORMATION

Item 4   Submission of Matters to a Vote of Security Holders............13

Item 6.  Exhibits and Reports on Form 8-K...............................13

         Signatures.....................................................14


                                  2

<PAGE>



PART 1.                       FINANCIAL INFORMATION

ITEM 1.                       FINANCIAL STATEMENTS

                    WALSH INTERNATIONAL INC AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF OPERATIONS

Dollars in thousands, except per share amounts, unaudited

<TABLE>
<CAPTION>
                                      -------------------------------------------------------------------------------------
                                                Three Months Ended                            Six Months Ended
                                          December 31,           December 31,           December 31,         December 31,
                                      -----------------      -----------------     ------------------     ----------------
                                                  1997                   1996                   1997                 1996
                                      -----------------      -----------------     ------------------     ----------------
<S>                                   <C>                      <C>                  <C>                   <C>            
Revenue                               $         15,400         $       13,353       $         29,274      $        26,111
                                      -----------------      -----------------     ------------------     ----------------
Costs and expenses:
   Production costs                              5,801                  4,921                 11,000                9,774
   Selling, general and
administrative expenses                          6,433                  6,117                 12,647               12,195
   Research and development costs                  966                    957                  1,729                1,919
    In process research and
development write-off                                -                      -                  2,000                    -
   Amortization of intangible assets                49                     36                    118                   72
                                      -----------------      -----------------     ------------------     ----------------
Total costs and expenses                        13,249                 12,031                 27,494               23,960
                                      -----------------      -----------------     ------------------     ----------------
Operating profit                                 2,151                  1,322                  1,780                2,151
Interest income                                    119                    229                    268                  419
Income expense                                     (97)                   (79)                  (138)                (133)
Minority Interest                                  (36)                    39                    (45)                 112
                                      -----------------      -----------------     ------------------     ----------------
Income before income taxes                       2,137                  1,511                  1,865                2,549
Income tax provision                              (577)                  (388)                (1,044)                (624)
                                      -----------------      -----------------     ------------------     ----------------
Net income                              $        1,560         $        1,123        $           821      $         1,925,
                                      =================      =================     ==================     ================

Basic earnings per share                $         0.15        $          0.11        $          0.08      $          0.18
                                      =================      =================     ==================     ================
Diluted earnings per share              $         0.14        $          0.11        $          0.08      $          0.18
                                      =================      =================     ==================     ================
Shares used in computing basic              10,579,095             10,486,848             10,563,309           10,482,041
earnings per share
                                      =================      =================     ==================     ================
Shares used in computing diluted            10,793,074             10,648,329             10,787,931           10,651,030
earnings per share
                                      =================      =================     ==================     ================
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                       3

<PAGE>



                    WALSH INTERNATIONAL INC AND SUBSIDIARIES

                           CONSOLIDATED BALANCE SHEETS

Dollars in thousands, unaudited
<TABLE>
<CAPTION>
                                                                        -------------------- --- --------------------
                                                                            DECEMBER 31                JUNE 30
                                                                               1997                     1997
                                                                        --------------------     --------------------
<S>                                                                     <C>                      <C>                
ASSETS
Current assets:
    Cash and cash equivalents                                           $             4,712      $             5,784
    Marketable securities                                                             5,653                    6,803
    Accounts receivable, principally trade                                           15,086                   14,227
    Prepaid expenses and other current assets                                           632                      702
                                                                        --------------------     --------------------
Total current assets                                                                 26,083                   27,516
Property and equipment, net                                                           3,911                    4,169
Goodwill, net                                                                         5,138                    3,439
Marketable securities                                                                 3,214                    1,437
Other assets, net                                                                     4,514                    3,727
                                                                        ====================     ====================
Total assets                                                             $           42,860       $           40,288
                                                                        ====================     ====================

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
    Current maturities of long-term debt                                $               159       $               17
    Current portion of capital lease obligations                                        470                      509
    Accounts payable                                                                  6,713                    6,896
    Accrued liabilities                                                              10,032                   11,166
    Unearned income                                                                   4,447                    4,103
                                                                        --------------------     --------------------
Total current liabilities                                                            21,821                   22,691
                                                                        --------------------     --------------------
Long-term debt                                                                        4,059                    1,260
Capital lease obligations                                                             1,475                    1,407
Other liabilities                                                                     4,327                    5,145
Minority interest                                                                       173                      128
Commitments
Stockholders' equity:
    Common stock, $0.01 par value, 20,000,000
    shares authorized and 10,584,324 and 10,533,960
    shares issued, respectively                                                         105                      105
Paid-in capital                                                                     119,786                  119,475
Accumulated deficit                                                                (109,337)                (110,158)
Cumulative translation adjustment                                                       870                      657
Unrealized gain on "available for sale" securities, net of tax                           38                       35
Treasury stock, at cost, 20,750 shares                                                 (457)                    (457)
                                                                        --------------------     --------------------
Total stockholders' equity                                                           11,005                    9,657
                                                                        ====================     ====================
Total liabilities and stockholders' equity                               $           42,860       $           40,288
                                                                        ====================     ====================
</TABLE>

   The accompanying notes are an integral part of these financial statements.


                                       4

<PAGE>



                    WALSH INTERNATIONAL INC AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS


Dollars in thousands, unaudited


<TABLE>
<CAPTION>
                                                                        --------------------
                                                                           SIX MONTHS ENDED
                                                                              DECEMBER 31
                                                                        --------------------
                                                                           1997        1996
                                                                        -------     -------
<S>                                                                     <C>         <C>     
Net cash flows provided by (used in) operating activities               $ 1,501     $  (396)
                                                                        -------     -------

Cash flows used in investing activities:
    Purchases of marketable securities                                     (468)       (366)
    Acquisition of PMS Pty Ltd                                           (3,970)         --
    Capital expenditures                                                   (331)       (496)
    Capitalized software                                                   (484)       (482)
                                                                        -------     -------
Net cash used in investing activities                                    (5,253)     (1,344)
                                                                        -------     -------

Cash flows provided by (used in) financing activities:
    Common stock issuance costs                                              --        (951)
    Proceeds from issuance of bank loan                                   3,337          --
    Options exercised                                                       311         204
    Repayment of long-term debt/capital leases                             (196)       (135)
    Other                                                                   142          --
                                                                        -------     -------
                                                                        -------     -------
Net cash provided by (used in) financing activities                       3,594        (882)
                                                                        -------     -------

Effect of exchange rate movements                                          (914)          3
Net decrease in cash and cash equivalents                                (1,072)     (2,619)
Cash and cash equivalents at beginning of period                          5,784       8,629
                                                                        =======     =======
Cash and cash equivalents at end of period                              $ 4,712     $ 6,010
                                                                        =======     =======
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                       5

<PAGE>



                    WALSH INTERNATIONAL INC AND SUBSIDIARIES

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)



1.       INTERIM UNAUDITED FINANCIAL INFORMATION

         The  consolidated  financial  statements  include the accounts of Walsh
         International  Inc.  (the  "Company")  and  all of  its  majority-owned
         subsidiaries.

         The  accompanying  consolidated  statements of operations for the three
         and six months  ended  December  31,  1997 and 1996,  the  consolidated
         statements of cash flows for the six months,  the consolidated  balance
         sheet as of  December  31, 1997 and the  related  information  of Walsh
         International   Inc.  included  in  these  notes  to  the  consolidated
         financial statements are unaudited.  In the opinion of management,  the
         interim financial information reflects all adjustments (consisting only
         of  items  of  a  normal  recurring  nature)  necessary  for  the  fair
         presentation of the financial position,  results of operations and cash
         flows for the periods  presented.  Results of operations  for the three
         months and six  months  ended  December  31,  1997 are not  necessarily
         indicative of the results to be expected for the entire year.

         The June 30, 1997 balance sheet was derived from the Company's June 30,
         1997 audited consolidated  financial  statements,  but does not include
         all disclosures required by generally accepted accounting principles.

         These interim  financial  statements should be read in conjunction with
         the audited consolidated financial statements and related notes thereto
         included in the Company's Form 10-K for the year ended June 30, 1997.


2.       EARNINGS PER SHARE

         The  Company  has  adopted the  Financial  Accounting  Standards  Board
         ("FASB") issued Statement of Financial Accounting Standard ("SFAS") No.
         128 "Earnings Per Share".  Basic  earnings per share is computed  using
         the  weighted  average  number of shares of Common  Stock  outstanding.
         Diluted  earnings per share includes common  equivalent  shares,  where
         dilutive,  from stock  options and warrants  (using the treasury  stock
         method).  All historical  periods presented have been restated applying
         SFAS 128.

         For all periods  presented income used in both basic earnings per share
         and the diluted earnings per share calculations is net income as stated
         in the consolidated statement of operations. The only common equivalent
         shares in the diluted  calculations are stock options  calculated using
         the treasury stock method. These calculations are summarised below:

                                       6

<PAGE>


<TABLE>
<CAPTION>
                                                 --------------------------------------    -------------------------------------- 
                                                          Three Months Ended                         Six Months Ended             
                                                     December 31,         December 31,         December 31,         December 31,  
                                                 -----------------    -----------------    ----------------     ----------------- 
                                                       1997                 1996                 1997                 1996        
                                                   -----------          -----------          -----------          ------------    
                                                                                                                                  
<S>                                                 <C>                  <C>                  <C>                  <C>            
Weighted average common shares outstanding (basic)  10,579,095           10,486,848           10,563,309           10,482,041 
Assumed exercise of in the money stock
options                                                740,675              645,501              752,019              661,689 
Less assumed buy-back under the treasury stock
method                                                (526,696)            (484,110)            (527,397)            (492,700)
                                                   -----------          -----------          -----------          ----------- 
Shares used in diluted earnings per share           10,793,074           10,648,239           10,787,931           10,651,030 
                                                   -----------          -----------          -----------          ----------- 
</TABLE>

         Options to  purchase  425,675  and  341,475  shares of common  stock at
         prices  ranging from $10.25 to $12.00 were  outstanding at December 31,
         1997 but were not included in the  computation of diluted  earnings per
         share  for  the  three  and  six  months   ended   December  31,  1997,
         respectively,  because the options' exercise price was greater than the
         average market price of the common shares.

3.       INCOME TAXES

         For the three and six months ended  December 31, 1997 the effective tax
         rates  were  27%  and  56%   respectively   compared  to  26%  and  25%
         respectively  for the  equivalent  periods of fiscal 1996.  For the six
         months  to  December  31,  1997,  the  effective  income  tax  rate was
         negatively  impacted by the non-deductible  charge for the write-off of
         in  process  research  and  development  costs  offset,  in part,  by a
         reduction  of taxes  provided in prior  years.  For 1996 the  effective
         income tax rate was  impacted by a reduction  of taxes  provided for in
         prior years.

4.       ACQUISITION OF PHARMACEUTICAL MARKETING SOLUTIONS PTY LTD

         In July 1997 the Company acquired 100% of the equity of  Pharmaceutical
         Marketing  Solutions Pty Ltd (PMS) a privately held Australian  company
         for $3.8  million in cash and $0.6  million of  associated  acquisition
         costs. PMS uses a salesforce automation system based on Lotus Notes and
         an analysis  system which operates as an integration  product between a
         data  warehouse  and  proprietary  salesforce  automation  system.  The
         acquisition  has been  accounted  for by the  purchase  method  and the
         results of operations of PMS have been included in the income statement
         from the acquisition date.


                                       7

<PAGE>




         The total purchase price of $4.4 million has been allocated as:

                  In Process Research and Development         $2.0
                  Completed Technology                        $0.6
                  Goodwill                                    $1.8
                                                              -----
                                                              $4.4
                                                              -----

         The  goodwill is expected to have an economic  life of 20 years and the
         completed  technology  a life of  between 3 and 5 years.  Goodwill  and
         completed  technologies  are being  amortised on a straight  line basis
         over their  economic  lives.  The in process  research and  development
         costs have been written off immediately.

         Pro-forma  results from operations of the Company as if the acquisition
         of PMS had  occurred on July 1, 1996 for the three and six months ended
         December 31, 1996 are:

                                          Three Months Ended   Six Months Ended
                                          December 31, 1996    December 31, 1996
              Revenue                           $14,218          $27,467
              Net Income                        $ 1,176          $ 1,925
              Basic Earnings per Share          $ 0.11            $ 0.18

         For the six months ended December 31, 1997 the  difference  between the
         pro-forma  operating results of the acquisition of PMS on the Company's
         actual operating results, had the acquisition occurred on July 1, 1997,
         was not material.

         On October 14, 1997 the Company obtained an Australian  dollar variable
         rate  commercial  loan  facility  of  $3.3  million  (Australian  $ 4.5
         million).  The term of this  facility is 5 years with annual  principle
         repayments  of  approximately  $660,000  commencing in year 2. Interest
         accrues at a variable rate (5.25% during the quarter).  $3.2 million of
         the total  marketable  securities  were pledged as collateral  for this
         loan. In January 1998 the Company repaid the loan in full.

5.       STOCKHOLDER RIGHTS PLAN.

         On October 14, 1997 the Board of Directors adopted a stockholder rights
         plan and declared a dividend of one right (a "Right") for each share of
         common  stock of the  Company.  The Rights  were  payable to holders of
         record of the common  stock of the  Company at the close of business on
         October  27,  1997.  The  Rights  will  automatically  trade  with  the
         Company's common stock.  Additional rights are issuable upon subsequent
         issuances  of common stock by the Company so long as the Rights Plan is
         in effect.

         The Rights are not currently  exercisable but become  exercisable  upon
         the earlier of i) ten days after the first public  announcement  that a
         person or group,  which did not beneficially own 5% of the common stock
         as of September  22,  1997,  has  acquired  beneficial  ownership of 15
         percent or more of the Company's  common stock or ii) ten business days
         after a person or group  announces an offer the  consummation  of which


                                       8

<PAGE>



         would result in such person or group beneficially  owning 15 percent or
         more of the Company's common stock.

         Once  exercisable  the holder  will be entitled to buy from the Company
         one  one-hundredth  of a share of new series B of junior  participating
         preferred  stock,  of which 250,000  shares have been  authorised,  for
         $55.00  per  Right or in  certain  circumstances  to buy at the  Rights
         exercise price a number of shares of the Company's  common stock having
         a market  value of twice the  exercise  price of each  Right or, if the
         Company is  acquired in a merger or a business  combination,  to buy at
         the  Rights  exercise  price a number of  shares of common  stock of an
         acquiring  Company having a market value of twice the exercise price of
         each Right. At the Company's  option the Rights are redeemable prior to
         becoming exercisable for $0.001 per Right. The Rights expire on October
         14, 2007.

         Preferred  shares  purchasable  upon exercise of the Rights will not be
         subject to  redemption  by the Company.  Each  preferred  share will be
         entitled to a minimum preferential  quarterly dividend payment of $0.01
         per  share  but  will  be  entitled  to an  aggregate  dividend  of 100
         multiplied by the dividend  declared per common  share.  Each holder of
         preferred  stock will be entitled to 100 votes per share on each matter
         on which holders of the common stock are entitled to vote.

6.       EMPLOYEE STOCK PURCHASE PLAN

         An Employee  Stock  Purchase  Plan (the "ESPP") has been adopted by the
         Company and the ESPP was approved on October 23, 1997 at the  Company's
         Annual Meeting of Stockholders.

         Under the ESPP  which is  intended  to qualify  as an  "employee  stock
         purchase plan" under Section 423 of the Internal Revenue Code,  options
         to  purchase  shares  of  Common  Stock  will be  granted  to  eligible
         employees of the Company and its  subsidiaries  at an exercise price of
         85% of the fair market value of the shares of Common  Stock  subject to
         such option on the date of grant,  based upon the closing  price of the
         Common Stock on the NASDAQ National Market.

         An aggregate of 100,000  shares of Common Stock have been  reserved for
         issuance  pursuant to the ESPP. To date there have been no grants under
         the ESPP.

7.       SUBSEQUENT EVENT

         In  January 1998,  the Company  repaid the  Australian A$4.5m  variable
         rate commerical loan facility in full.


                                       9

<PAGE>



ITEM 2

               MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF
                       OPERATIONS AND FINANCIAL CONDITION

                    WALSH INTERNATIONAL INC. AND SUBSIDIARIES

THREE MONTHS ENDED DECEMBER 31, 1997 AND 1996

Revenue for the Company's  second quarter of fiscal year ended June 30, 1998 was
$15.4 million, growth of 26% excluding the adverse impact of currency movements.
The  increase  was  due  to  the  growth  in the  Company's  technology  product
(PREMIERE,  Precise and  Pharbase)  revenues and to a lesser  degree direct mail
marketing revenues. Growth was most notable in the European and Pacific markets.

Production  costs for the quarter were $5.8 million (37.7% of revenue)  compared
to $4.9 million  (36.9% of revenues)  in the  comparable  quarter of fiscal year
1997.  The  increase  in  production  costs for the quarter as a  percentage  of
revenues reflects the inclusion of some low margin third party software revenues
as well as an  increase in lower  margin  direct  mail  marketing  revenues as a
percentage of revenue  following the  acquisition  of  Pharmaceutical  Marketing
Solutions Pty Ltd (PMS), a privately owned Australian company, in July 1997. The
$0.9 million  increase in production costs has arisen for the above reasons plus
continued  investment  in  technical  staff for roll-out and support of PREMIERE
installations.

Selling,  general and administrative  expenses in the second quarter of the year
were $6.4 million  (41.8% of revenues)  versus $6.1 million  (45.8% of revenues)
for the same  quarter of the prior year.  This  increase is  primarily  due to a
number of new account executives for the higher number of PREMIERE clients.  The
decrease in SG&A  expenses in the quarter as a percentage  of revenues  reflects
the Company's operating leverage, whereby such costs do not increase directly in
proportion  to the  revenues.  During  the  quarter,  some one time  charges  of
$235,000  were  incurred  relating to the  relocation  of operations in Phoenix,
Arizona to Newtown,  Pennsylvania in order to improve efficiencies.  The closure
costs were offset by the  reassessment  of a previously  established  accrual no
longer required.

Research and  development  costs were $1.0 million,  the same level as the three
months ended December 31, 1996.

Net interest  income for the quarter ended  December 31, 1997 was $22,000 verses
$150,000  in the  comparable  quarter of fiscal 1997 which is due  primarily  to
increased debt  totalling  A$4.5 million which was taken out at the beginning of
the quarter to fund the acquisition of PMS.

SIX MONTHS ENDED DECEMBER 31, 1997 AND 1996

Revenue for the first half of fiscal year ended June 30, 1998 was $29.3 million,
an increase of 21%, excluding the impact of currency, which comes primarily from
the increase in the Company's technology  products.  The largest increase was in
the  Pacific  markets  which  comprises  a mixture  of  organic  growth  and the
acquisition of PMS.


                                       10

<PAGE>



Production  costs for the six months  were  $11.0  million  (37.6% of  revenues)
versus $9.8 million  (37.4% of  revenues)  for the  comparable  period of fiscal
1997. The increase in production  costs  reflects the  continuing  investment in
technical  staff for the roll-out and support for PREMIERE and  increased  lower
margin direct mail revenues  resulting from the acquisition of PMS. The increase
as a  percentage  of revenue  reflects  the sale of some low margin  third party
software  plus  increased  lower  margin  direct  mail  revenues  as a result of
acquiring PMS.

Selling,  general  and  administrative  expenses  were $12.6  million  (43.2% of
revenues)  versus $12.2 million  (46.7% of revenues) for the first six months of
1997.  This reflects the Company's  continued  investment in sales resources and
client service personnel to meet the growing demand for PREMIERE.

Research and  development  costs for the six months ended December 31, 1997 were
$1.7 million  (5.9% of revenues)  versus $1.9 million (7.3% of revenues) for the
comparable  quarter of fiscal  1997.  The  decline  is due to  foreign  exchange
differences  and the  reassignment of some research staff working on support for
the delivered product.

An in process  research and  development  write-off  totalling  $2.0 million has
arisen as a result of the  acquisition  of PMS.  The $2.0  million  is the value
attributable to acquired  technology  products which are to be integrated within
the Company's own salesforce management information system, PREMIERE.

Net interest income for the half year to December 31, 1997 is $0.1m versus $0.3m
in the six months to December 31, 1996. This primarily  reflects the acquisition
of PMS in July 1997 funded initially by cash and subsequently by debt.

                         LIQUIDITY AND CAPITAL RESOURCES

At December 31, 1997,  the  Company's  cash and cash  equivalents  totalled $4.7
million,  a decrease of $1.1 million  from the $5.8 million  balance at June 30,
1997. The Company  generated  $1.5 million of cash from operating  activities in
the six months ended  December  1997 due to improved  profitability  and working
capital  management.  Total cash has fallen since June 30, 1997 due primarily to
the acquisition of PMS together with adverse exchange movements.

The  Company  additionally  holds  $8.9  million  in  a  professionally  managed
portfolio  of  marketable  securities.  $3.2  million  of these  securities  are
classified  as  non-current  assets  as  they  provide  collateral  against  the
Australian dollar debt.  Subsequent to quarter ended December 31, 1997 this debt
was repaid in full.

The Company believes that the anticipated cash flow from operations and existing
cash balances will satisfy the Company's  projected  working capital and capital
expenditure requirements through at least the end of fiscal 1999.


                                       11

<PAGE>



                      RECENTLY ISSUED ACCOUNTING STANDARDS

In June 1997,  the FASB issued SFAS No. 130,  "Reporting  Comprehensive  Income"
which is effective for financial  statements  issued for fiscal years commencing
on or after December 15, 1997. Comprehensive income represents the change in net
assets of a company  as a result  of  non-owner  transactions.  The  Company  is
currently  evaluating  the new standard and does not believe that it will have a
significant impact.

In October 1997, the AICPA issued Statement of Position 97-2,  "Software Revenue
Recognition"  which is effective  for  transactions  entered into by the Company
commencing  July 1, 1998.  The Company is currently  evaluating the new standard
and does not believe  that it will have a  significant  impact on the  Company's
current revenue recognition policy.



                                       12

<PAGE>




PART II  OTHER INFORMATION

ITEM 4   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         At the Company's 1997 Annual Meeting of  Stockholders,  held on October
         23, 1997, an aggregate of 8,419,405 shares of Common Stock were present
         in person or by proxy. Votes cast for and against,  and abstentions for
         the matters submitted to a vote of security-holders were as follows:

         (i)   Election of Directors:

                                                              AUTHORITY TO
         NOMINEE                   VOTES FOR                  VOTE WITHHELD

         Michael A. Hauck          8,397,255                  22,150
         Leonard M. Lodish         8,396,655                  22,750

         (ii)  Approval of Employee Stock Purchase Plan

         VOTES FOR                 VOTES AGAINST              ABSTENTIONS

         7,544,815                 864,290                    10,300


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

A)       EXHIBITS
Exhibit
Number

3.1      Restated  Certificate of  incorporation  of Walsh  International  Inc.,
         incorporated by reference to Exhibit 3.1 to the Registration  Statement
         on Form S-1 of the Company (file no. 333-316).

3.2      By-laws  of Walsh  International  Inc.,  as  amended,  incorporated  by
         reference to Exhibit 3.2 to the  Registration  Statement on Form S-1 of
         the Company (file no. 333-316).

10.1     Letter   Agreement  dated  as  of  October  27th,  1997  between  Walsh
         International Inc. and Dennis M.J. Turner.

11       Computation of Earnings (Loss) per Share

27       Financial Data Schedule

b)       Reports on Form 8-K


                                       13

<PAGE>



                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


DATE: FEBRUARY 13, 1998                    WALSH INTERNATIONAL INC.




                                             BY /s/ Martyn D. Williams
                                                --------------------------------
                                                MARTYN D. WILLIAMS
                                                CHIEF FINANCIAL OFFICER



                                              ON BEHALF OF THE REGISTRANT AND AS
                                                     PRINCIPAL FINANCIAL OFFICER

                                       14

<PAGE>



                                INDEX TO EXHIBITS


Exhibit           Description


3.1      Restated  Certificate of  Incorporation  of Walsh  International  Inc.,
         incorporated by reference to Exhibit 3.1 to the Registration  Statement
         on Form S-1 of the Company (file no. 333-316).

3.2      By-laws  of Walsh  International  Inc.,  as  amended,  incorporated  by
         reference to Exhibit 3.2 to the  Registration  statement on Form S-1 of
         the Company (file no. 333-316).

10.1     Letter   Agreement  dated  as  of  October  27th,  1997  between  Walsh
         International Inc. and Dennis M.J. Turner.

11       Computation of Earnings per Share

27       Financial Data Schedule


                                       15